Description

Product Overview

Retatrutide is a next-generation triple-agonist research peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. This triple mechanism of action represents the cutting edge of metabolic research, showing unprecedented effects on weight management and metabolic parameters in preclinical and clinical studies.

Key Benefits

✅ Triple receptor activation (GLP-1 + GIP + Glucagon)
✅ Most potent weight management peptide in current research
✅ Enhanced energy expenditure via glucagon receptor activation
✅ Appetite suppression and delayed gastric emptying
✅ Improved insulin sensitivity and glucose homeostasis
✅ Increased lipolysis and fat oxidation
✅ Once-weekly research protocol

Research Data

Type: Triple GLP-1/GIP/Glucagon receptor agonist
Half-Life: ~144 hours (6 days)
Molecular Weight: ~4,900 g/mol
Research Protocol: Start at 2mg/week, titrate every 4 weeks
Research Dose Range: 2mg to 12mg/week
Administration: Subcutaneous injection once weekly

Storage & Handling

Lyophilized powder: store at -20°C. After reconstitution with bacteriostatic water, refrigerate at 2-8°C. Use within 30 days. Avoid freeze-thaw cycles. Protect from UV light exposure.

Quality Assurance

🔬 HPLC tested and verified by independent ISO 17025 laboratory. Each batch comes with full Certificate of Analysis — available in the Lab Report tab on this product page. No exceptions, no hidden batches.

Important Notice

⚠️ For laboratory research purposes exclusively. Not for human or animal administration. This product is sold as a research chemical. Appropriate laboratory safety protocols must be followed.